RXRX
Recursion Pharmaceuticals (RXRX) Investor Questions
Review Recursion Pharmaceuticals (RXRX) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Recursion Pharmaceuticals
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 43
- Annual revenue
- $74.26M
- Annual net income
- $-644.76M
- Annual free cash flow
- $-380.44M
Recursion Pharmaceuticals (RXRX) Investor Questions research
Recursion Pharmaceuticals trades under the ticker RXRX. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review RXRX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.